I-5-Aminoindole CAS 5192-03-0 Ubumsulwa >98.0% (HPLC) Isithombe Esifakiwe Sefektri Sekhwalithi Ephezulu

I-5-Aminoindole CAS 5192-03-0 Ukuhlanzeka >98.0% (HPLC) Ifektri Yekhwalithi Ephezulu

Incazelo emfushane:

Igama Lekhemikhali: 5-Aminoindole

CAS: 5192-03-0

Ubumsulwa: >98.0% (HPLC)

Ukubukeka: Okumhlophe Kusuka Kumpushani Ensundu noma Amakristalu

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo kanye nomphakeli we-5-Aminoindole (CAS: 5192-03-0) enekhwalithi ephezulu, ukukhiqizwa kwezentengiso.Wamukelekile eku-odeni.

Chemical Properties:

Igama Lekhemikhali	5-Aminoindole
Omqondofana	1H-Indol-5-Amine;5-Amino-1H-Indole
Inombolo ye-CAS	5192-03-0
Inombolo yeCAT	I-RF-PI1604
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C8H8N2
Isisindo samangqamuzana	132.17
Iphuzu elibilayo	190 ℃ / 6mmHg
Ukuminyana	1.1083
Ukuncibilika	I-Soluble ku-Methanol;Ayincibiliki Emanzini
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Okumhlophe Kusuka Kumpushani Ensundu noma Amakristalu
1 H NMR Spectrum	Ihambisana Nesakhiwo
Ukuhlanzeka / Indlela Yokuhlaziya	>98.0% (HPLC)
I-Melting Point	130.0 ~ 135.0℃
Ukulahlekelwa Ekumisweni	<1.00%
Ukungcola Okuphelele	<2.00%
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediates

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-5-Aminoindole (CAS: 5192-03-0),Isabela ekulungiseleleni: I-Smac mimetics ebophezela kusizinda se-BIR2 se-anti-apoptotic protein XIAP;Ama-Cytotoxic kanye nama-antimitotic agents;I-insulin-like growth factor 1 receptor inhibitors;Ama-Antitumoral agents;I-Factor Xa inhibitor;Ama-antivascular agents angaba khona;Ukubhalwa kwe-Gli1-mediated ku-Hedgehog pathway;Ama-inhibitors we-receptor tyrosine kinase anemiphumela ye-antiangiogenic;I-HIV protease inhibitors.